Aeolus Pharmaceuticals Initiates Pivotal Animal Study Of AEOL 10150 As A Countermeasure To Radiation Exposure

Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced today that it has initiated the first of two expected pivotal studies of AEOL 10150 as a countermeasure to nuclear and radiological exposure. The study, led by Zeljko Vujaskovic, M.D. Ph.D.

More: continued here

Filed under: Bio-terrorism on November 25th, 2008

Comments are closed.

« Ventura County, Calif., Effort Seeks To Encourage Hispanics To Talk Openly About HIV/AIDS Making Male Circumcision A Top-Tier HIV Prevention Strategy With $18.5 Million Grant »

Online RX Store - Buy Drugs: Store for Rx products
RX Pills Shop - Buy Drugs: RX pills shop
RX Pills Store - Buy Drugs: RX pills sotre
RX Discount Plus - Buy Drugs: Discount plus - A method that you get extra money even if you take discount products.
Rx Pills for You - : Rx Pills for You
Your Health Rx - : Your Health Rx
Drug any time - : Drug any time
Travellers pharmacy - : Pharmacy for people that travel
Latest News...